Clozapine initiation in the community

Psychiatric Bulletin

Volumn 26, Issue 9, 2002, Pages 339-341

  O'Brien, Aileen ^a   Firn, Mike ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; COMMUNITY MENTAL HEALTH; DISEASE SEVERITY; DROWSINESS; DRUG CHOICE; DRUG MONITORING; EXPERIENCE; HEALTH CARE POLICY; HOME CARE; HOSPITAL ADMISSION; HUMAN; MEDICAL DECISION MAKING; MENTAL DISEASE; NAUSEA; PATIENT ATTITUDE; PATIENT COMPLIANCE; RISK BENEFIT ANALYSIS; SEDATION; TREATMENT FAILURE; UNITED KINGDOM; VERTIGO;

EID: 0036729224     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.26.9.339     Document Type: Article

References (9)

1. Cost-effectiveness of clozapine. A UK clinic-based study
2. Long-term impact of clozapine and psychosocial treatment on psychiatric symptoms and cognitive functioning
3. Starting patients on clozapine in a partial hospitalisation programme
4. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
5. Clozapine in the management of schizophrenia. All schizophrenic patients would benefit
6. Health care costs of therapy - Refractory schizophrenic patients treated with clozapine: A study in a community psychiatric service in Italy
7. A comparison of clozapine and haloperidol in hospitalised outpatients with refractory schizophrenia
8. Alternative to mental hospital treatment. (1) Conceptual model, treatment program, and clinical evaluation